Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
1 - 10 of 48
- Francqui Chair prof. dr. SwinnenFrom1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Novel antibody biomarkers for the prediction of response to first-line therapy in rheumatoid arthritisFrom15 Jan 2023 → 14 Jan 2024Funding: IOF - technology concept exploration
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort.From1 Oct 2022 → 1 Dec 2023Funding: Foundations, funds and other with scientific goal
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Elucidating the role of double homeobox protein 4 (DUX4) in the pathology of inflammatory arthritisFrom1 Jan 2021 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Protective versus damaging aspects of the immune reaction in relation to clinical outcome in the Limburg COVID-19 cohortFrom15 Jun 2020 → 14 Jun 2022Funding: BOF - projects
Publications
11 - 20 of 130
- Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical Parameters(2022)
Authors: Judith FRAUSSEN, Lien BECKERS, CCM van Laake-Geelen, B Depreitere, J Deckers, EMJ Cornips, D Peuskens, Veerle SOMERS
- NOVEL ANTIBODY BIOMARKERS THAT PREDICT FAILURE TO ACHIEVE EARLY AND SUSTAINED DISEASE REMISSION OR LOW DISEASE ACTIVITY AFTER INTENSIVE FIRST-LINE THERAPY IN RHEUMATOID ARTHRITIS(2022)
Authors: Patrick VANDORMAEL, Astrid PUES, Ellen SLEURS, Jori LIESENBORGS, P. Verschueren, Veerle SOMERS
Pages: 299 - Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy(2022)
Authors: Valentino D'ONOFRIO, Lotte Keulen, Annelore Vandendriessche, Jasperina Dubois, Reinoud Cartuyvels, Marie-Elena Vanden Abeele, Judith FRAUSSEN, Patrick VANDORMAEL, Veerle SOMERS, Ruth ACHTEN, et al.
- Oligodendroglia-derived extracellular vesicles activate autophagy via LC3B/BAG3 to protect against oxidative stress with an enhanced effect for HSPB8 enriched vesicles(2022)
Authors: Bram VAN DEN BROEK, Charlotte Wuyts, Angela Sisto, Isabel Pintelon, Jean-Pierre Timmermans, Veerle SOMERS, Vincent Timmerman, Niels HELLINGS, Joy IROBI
- Characterisation of the innate and adaptive immune system after ocrelizumab treatment in multiple sclerosis(2021)
Authors: Lien BECKERS, Paulien BAETEN, Dries SWINNEN, Ibrahim HAMAD, S. Tavernier, Bart VAN WIJMEERSCH, Veronica POPESCU, Markus KLEINEWIETFELD, Bieke BROUX, Judith FRAUSSEN, et al.
Pages: 777 - 778 - Identification and characterization of novel antibody biomarkers for early axial spondyloarthritis(2021)
Authors: Dana QUADEN, Veerle SOMERS
Number of pages: 259 - DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation(2021)
Authors: Renzo Riemens, Ben ROMBAUT, Patrick VANDORMAEL, Veerle SOMERS, Jos Prickaerts, Niels HELLINGS, Daniel van den Hove, Tim VANMIERLO
- Pulsed Thermal Method for Monitoring Cell Proliferation in Real-Time(2021)
Authors: Seppe BORMANS, Gilles OUDEBROUCKX, Patrick VANDORMAEL, Thijs VANDENRYT, Patrick WAGNER, Veerle SOMERS, Ronald THOELEN
- IgD-CD27-double negative (DN) B cells of multiple sclerosis patients are mature memory cells that can migrate towards pro-inflammatory chemokines(2021)
Authors: Lien BECKERS, Gwendoline MONTES DIAZ, Luisa Maria Villar, Bart VAN WIJMEERSCH, Veronica POPESCU, Veerle SOMERS, Judith FRAUSSEN
Pages: 187 - IMMUNOGLOBULIN G ANTIBODIES TO THREE NOVEL PEPTIDES IN EARLY AXIAL SPONDYLOARTHRITIS IN TWO INDEPENDENT COHORTS(2021)
Authors: Dana QUADEN, Patrick VANDORMAEL, Pieter RUYTINX, Piet GEUSENS, Johan VANHOOF, K. de Vlam, Veerle SOMERS
Pages: 1212 - 1213
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)
Linked dataset
1 - 1 of 1